267 related articles for article (PubMed ID: 4901055)
1. L-dopa and amantadine in the therapy of parkinsonism.
Weeth JB; Shealy CN; Mercier DA
Wis Med J; 1969 Nov; 68(11):325-8. PubMed ID: 4901055
[No Abstract] [Full Text] [Related]
2. Combined treatment of parkinsonism with L-dopa and amantadine.
Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP
Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690
[No Abstract] [Full Text] [Related]
3. L-dopa and amantadine hydrochloride in Parkinson's disease.
Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
[No Abstract] [Full Text] [Related]
4. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
Sigwald J; Raymondeaud C; Piot C
Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
[No Abstract] [Full Text] [Related]
5. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
Schwab RS; England AC
Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
[No Abstract] [Full Text] [Related]
6. [Use of L-DOPA in the therapy of parkinsonism].
D'Andrea F; De Divitiis E; Signorelli CD; Cerillo A; Tedeschi G
Rass Int Clin Ter; 1971 Feb; 51(4):193-221. PubMed ID: 4930734
[No Abstract] [Full Text] [Related]
7. Combined L-dopa and amantadine in Parkinsonism.
Pollock M; Jorgensen PB
Aust N Z J Med; 1972 Aug; 2(3):252-5. PubMed ID: 4564049
[No Abstract] [Full Text] [Related]
8. [Amantadine therapy in parkinsonism].
Pakkenberg H
Ugeskr Laeger; 1973 Jan; 135(3):135-6. PubMed ID: 4685048
[No Abstract] [Full Text] [Related]
9. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
Reveno WS; Bauer RB; Rosenbaum H
Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
[No Abstract] [Full Text] [Related]
10. Clinical evaluation of amantadine therapy for parkinsonism and the side effects--in cases of thalamic surgery and L-dopa therapy.
Matsumoto K; Omoto T; Beck H
Folia Psychiatr Neurol Jpn; 1974 Jan; 28(1):1-10. PubMed ID: 4406943
[No Abstract] [Full Text] [Related]
11. Treatment of Parkinson's disease with amantadine and L-Dopa.
Rinne UK; Sonninen V; Siirtola T
Eur Neurol; 1972; 7(4):228-40. PubMed ID: 4556618
[No Abstract] [Full Text] [Related]
12. L-dopa and amantadine for Parkinsonism.
Drug Ther Bull; 1970 Aug; 8(17):65-7. PubMed ID: 5480244
[No Abstract] [Full Text] [Related]
13. [Treatment of Parkinson's syndrome with L-dopa associated with diphenhydramine hydrochloride and amantadine hydrochloride].
Scotti G
Sist Nerv; 1970; 22(2):144-52. PubMed ID: 5504553
[No Abstract] [Full Text] [Related]
14. [Amantadine. Prolonged clinical trial in 50 parkinsonian patients].
Castaigne P; Laplane D; Dordain G
Nouv Presse Med; 1972 Feb; 1(8):533-6. PubMed ID: 5012351
[No Abstract] [Full Text] [Related]
15. L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.
Yahr MD; Duvoisin RC; Hoehn MM; Schear MJ; Barrett RE
Trans Am Neurol Assoc; 1968; 93():56-63. PubMed ID: 4885744
[No Abstract] [Full Text] [Related]
16. [Potentiation of L-Dopa in parkinsonism by means of an inhibitor of peripheral decarboxylation].
Court J; Kase JC; Mena I; Palacios E
Rev Med Chil; 1973 Jun; 101(6):452-5. PubMed ID: 4764560
[No Abstract] [Full Text] [Related]
17. Metabolism and clinical assessment of L-dopa in parkinsonism.
Ericsson AD; McCann D; Sharpless N; Reveno W
Neurology; 1970 Apr; 20(4):402. PubMed ID: 4935027
[No Abstract] [Full Text] [Related]
18. [Treatment of Parkinson's disease with amantadine].
Sigwald J; Raymondeaud C; Grégoire J
Therapeutique; 1972 Nov; 48(9):555-60. PubMed ID: 4568230
[No Abstract] [Full Text] [Related]
19. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
Hacohen H; Gurtner B
Schweiz Med Wochenschr; 1972 Apr; 102(16):583-6. PubMed ID: 5019377
[No Abstract] [Full Text] [Related]
20. [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].
Ferel D
Schweiz Med Wochenschr; 1972 Jan; 102(3):88-94. PubMed ID: 4551909
[No Abstract] [Full Text] [Related]
[Next] [New Search]
